Starsource Multitrade (506365) Q4 07/08 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 07/08 earnings summary
21 Oct, 2026Executive summary
Manufacturing remained discontinued throughout FY08; activity centered on share trading and other investments, with diversification opportunities still being explored.
Aggregate income was Rs 8.40 lakh and profit after tax was Rs 0.08 lakh, down from Rs 1.20 lakh in FY07.
Financial highlights
Income was Rs 839,522 vs Rs 30,526,656 in FY07; FY08 included dividend income of Rs 315,834, share-sale profit of Rs 515,287 and sundry balances written back of Rs 8,400.
Profit before depreciation was Rs 134,564 vs Rs 193,364; depreciation was Rs 126,338 vs Rs 73,237; profit after tax was Rs 8,226 vs Rs 120,127.
Other expenses were Rs 699,503 vs Rs 30,298,235; prior-year costs included Rs 27,066,020 in service charges.
Accumulated P&L debit balance declined to Rs 29,672,704 from Rs 29,680,930.
Outlook and guidance
Directors were exploring new business avenues as manufacturing was unviable; diversification had made no significant progress during FY08.
Latest events from Starsource Multitrade
- Tax write-back lifted net profit as factory operations restarted and Fine Chemicals trials advanced.506365
Q4 96/97 - A continuing factory lockout and Rs. 83,23,334 pre-tax loss defined the year.506365
Q4 97/98 - Continued lockout, Rs.4.488m net loss, and major unprovided liabilities and investment impairment.506365
Q4 98/99 - Lockout and a widening Rs.4.38m loss drove plans to explore disposal or leasing.506365
Q4 04/05 - Lockout halted operations; FY2002-03 net loss was Rs.863,221 as leasing talks continued.506365
Q4 02/03 - Manufacturing ceased after asset sales; diversification and material financial risks remain.506365
Q4 06/07 - Suspended manufacturing, falling income and auditor-flagged asset and loan risks defined FY10.506365
Q4 09/10 - A modest return to profit amid suspended operations, material audit concerns, and suspended share trading.506365
Q4 10/11 - Investment-sale income drove FY12 profit as manufacturing remained suspended.506365
Q4 11/12